1. Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08. Issue 10 (July 2015) Authors: Zaman, Khalil; Winterhalder, Ralph; Mamot, Christoph; Hasler-Strub, Ursula; Rochlitz, Christoph; Mueller, Andreas; Berset, Catherine; Wiliders, Hans; Perey, Lucien; Rudolf, Christine Biaggi; Hawle, Hanne; Rondeau, Stephanie; Neven, Patrick Journal: European journal of cancer Issue: Volume 51:Issue 10(2015:Jul.) Page Start: 1212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First‐Line Docetaxel: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial (SAKK 08/11). Issue 16 (25th July 2016) Authors: Cathomas, Richard; Crabb, Simon J.; Mark, Michael; Winterhalder, Ralph; Rothermundt, Christian; Elliott, Tony; von Burg, Philippe; Kenner, Heike; Hayoz, Stefanie; Vilei, Simona Berardi; Rauch, Daniel; Roggero, Enrico; Mohaupt, Markus G.; Bernhard, Jürg; Manetsch, Gabriela; Gillessen, Silke Journal: Prostate Issue: Volume 76:Issue 16(2016) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to Pembrolizumab in a Patient with Relapsing Thymoma. Issue 12 (December 2016) Authors: Zander, Thilo; Aebi, Stefan; Rast, Anna Christina; Zander, Andrea; Winterhalder, Ralph; Brand, Christoph; Diebold, Joachim; Gautschi, Oliver Journal: Journal of thoracic oncology Issue: Volume 11:Issue 12(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial. Issue 1 (December 2016) Authors: Rochlitz, Christoph; Bigler, Martin; von Moos, Roger; Bernhard, Jürg; Matter-Walstra, Klazien; Wicki, Andreas; Zaman, Khalil; Anchisi, Sandro; Küng, Marc; Na, Kyung-Jae; Bärtschi, Daniela; Borner, Markus; Rordorf, Tamara; Rauch, Daniel; Müller, Andreas; Ruhstaller, Thomas; Vetter, Marcus; Trojan,... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Severe Hyperkalemia and Bilateral Adrenal Metastasis. (10th February 2010) Authors: Nagler, Michael; Müller, Beat; Briner, Verena; Winterhalder, Ralph Other Names: Neven Patrick Academic Editor. Journal: Journal of oncology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Severe Hyperkalemia and Bilateral Adrenal Metastasis. (10th February 2010) Authors: Nagler, Michael; Müller, Beat; Briner, Verena; Winterhalder, Ralph Other Names: Neven Patrick Academic Editor. Journal: Journal of oncology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Clinical Value of Echocardiography and Acoustic Cardiography to Monitor Patients Undergoing Anthracycline Chemotherapy. Issue 4 (14th November 2012) Authors: Toggweiler, Stefan; Odermatt, Yvonne; Brauchlin, Andreas; Zander, Thilo; Müller, Andrea; Zuber, Michel; Winterhalder, Ralph; Erne, Paul Journal: Clinical cardiology Issue: Volume 36:Issue 4(2013:Apr.) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗